Jaka jest cena za IntelGenx Technologies Corp. (IGX)

Cena za IntelGenx Technologies Corp. (IGX) wynosi $0.17446996

Jaka jest kapitalizacja rynkowa dla IntelGenx Technologies Corp. (IGX)

Kapitalizacja rynkowa dla IntelGenx Technologies Corp. (IGX) wynosi $26.97M

IntelGenx Technologies Corp. (IGX) EPS

IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise focused on the creation and manufacturing of advanced oral thin film products. The company's diverse product pipeline encompasses various oral film formulations designed to address a wide spectrum of medical conditions. These include INT0008/2008, a Rizatriptan film for migraine management; INT0046/2018 for adult applications; INT0007/2006, an oral film targeting erectile dysfunction; INT0043/2015, a montelukast-based film for Alzheimer's disease; INT0027/2011, intended for opioid addiction treatment; INT0010/2006, addressing neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, formulated for schizophrenia or bipolar I disorder; and INT0048/2020, developed for veterinary health. Additionally, IntelGenx is actively developing other candidates identified as INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has established strategic partnerships, including a comprehensive licensing, development, and supply agreement with Tilray, Inc., alongside a development pact with Cynapsus Therapeutics Inc. Founded in 2003, IntelGenx Technologies Corp. is headquartered in Montreal, Canada.

Rok	EPS	Zmień
Za mało danych dla podanych dat.

Rok

EPS

Zmień

Za mało danych dla podanych dat.

Firma	EPS	Różnica w EPS	Kraj
Vertex Pharmaceuticals Incorporated VRTX.US	$17.32	-	US
Moderna, Inc. MRNA.US	$-7.98	-	US
Argenx SE ARGX.US	$27.74	-	NL
CSL Limited CSL.AX	$2.98	-	AU
Lonza Group AG LONN.SW	-	-	CH

Firma

EPS

Różnica w EPS

Kraj